首页> 外国专利> THERAPEUTIC ENGINEERED MICROBIAL CELL SYSTEMS AND METHODS FOR TREATING HYPERURICEMIA AND GOUT

THERAPEUTIC ENGINEERED MICROBIAL CELL SYSTEMS AND METHODS FOR TREATING HYPERURICEMIA AND GOUT

机译:治疗工程微生物细胞系统和治疗高尿酸血症和痛风的方法

摘要

The present disclosure relates to engineered microbial cells that have been engineered to include a uricase, a uric acid transporter, or both a uricase and a uric acid transporter. The engineered microbial cells of the present disclosure are useful in degrading uric acid inside the engineered microbial cell. The engineered microbial cells of the present disclosure are useful in methods of treating hyperuricemia. The engineered microbial cells of the present disclosure are also useful in methods of treating gout, and in particular chronic refractory gout.
机译:本公开涉及已经设计为包括尿素酶,尿酸转运蛋白和尿酸酸和尿酸转运蛋白的工程化微生物细胞。 本公开的工程化微生物细胞可用于降解工程微生物细胞内的尿酸。 本公开的工程微生物细胞可用于治疗高尿酸血症的方法。 本公开的工程化微生物细胞也可用于治疗痛风的方法,特别是慢性耐火痛风。

著录项

  • 公开/公告号WO2021142491A9

    专利类型

  • 公开/公告日2021-11-11

    原文格式PDF

  • 申请/专利权人 THERANEUTRICS LLC;

    申请/专利号WO2021US70014

  • 发明设计人 GEISLER CHRISTOPH;

    申请日2021-01-08

  • 分类号A61B34/30;

  • 国家 US

  • 入库时间 2022-08-24 22:29:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号